Access to this article is restricted until 12 months after publication by request of the publisher.. Restriction lift date: 2019-03-13
Polydopamine nanoparticles for treatment of acute inflammation-induced injury
dc.check.date | 2019-03-13 | |
dc.check.info | Access to this article is restricted until 12 months after publication by request of the publisher. | en |
dc.contributor.author | Zhao, He | |
dc.contributor.author | Zeng, Zhandong | |
dc.contributor.author | Liu, Lin | |
dc.contributor.author | Chen, Jiawen | |
dc.contributor.author | Zhou, Huiting | |
dc.contributor.author | Huang, Lili | |
dc.contributor.author | Huang, Jie | |
dc.contributor.author | Xu, Hua | |
dc.contributor.author | Xu, Yunyun | |
dc.contributor.author | Chen, Zhengrong | |
dc.contributor.author | Wu, Yi | |
dc.contributor.author | Guo, Wanliang | |
dc.contributor.author | Wang, Jiang Huai | |
dc.contributor.author | Wang, Jian | |
dc.contributor.author | Liu, Zhuang | |
dc.contributor.funder | Ministry of Science and Technology of the People's Republic of China | en |
dc.contributor.funder | National Natural Science Foundation of China | en |
dc.contributor.funder | Natural Science Foundation of Jiangsu Province | en |
dc.contributor.funder | Suzhou Municipal Science and Technology Project, China | |
dc.contributor.funder | Key Laboratory of Suzhou, China | |
dc.contributor.funder | Suzhou Clinical Medicine Center, China | |
dc.contributor.funder | Jiangsu Natural Science Fund for Distinguished Young Scholars | |
dc.contributor.funder | Jiangsu Higher Education Institutions, China | |
dc.contributor.funder | Collaborative Innovation Center of Suzhou Nano Science and Technology, China | |
dc.date.accessioned | 2018-03-27T08:59:15Z | |
dc.date.available | 2018-03-27T08:59:15Z | |
dc.date.issued | 2018-03-13 | |
dc.date.updated | 2018-03-21T12:03:11Z | |
dc.description.abstract | Nanotechnology-mediated anti-inflammatory therapy is emerging as a novel strategy for treatment of inflammation-induced injury. However, one of the main hurdles for these anti-inflammatory nano-drugs is their potential toxic side effects in vivo. Herein, we uncovered that polydopamine (PDA) nanoparticles with structure and chemical properties similar to melanin, a natural bio-polymer, displayed significant anti-inflammation therapeutic effect on acute inflammation-induced injury. PDA with enriched phenol groups functioned as a radical scavenger to eliminate reactive oxygen species (ROS) generated during inflammatory responses. As revealed by in vivo photoacoustic imaging with a H2O2-specific nanoprobe, PDA nanoparticles remarkably reduced intracellular ROS levels in murine macrophages challenged with either H2O2 or lipopolysaccharide (LPS). The anti-inflammatory capacity of PDA nanoparticles was further demonstrated in murine models of both acute peritonitis and acute lung injury (ALI), where diminished ROS generation, reduced proinflammatory cytokines, attenuated neutrophil infiltration, and alleviated lung tissue damage were observed in PDA-treated mice after a single dose of PDA treatment. Our work therefore presents the great promise of PDA nanoparticles as a biocompatible nano-drug for anti-inflammation therapy to treat acute inflammation-induced injury. | en |
dc.description.sponsorship | Ministry of Science and Technology of the People´s Republic of China (National Basic Research Programs of China - 973Program (2016YFA0201200)); National Natural Science Foundation of China (81602181, 81501703, 81500733, 81502500, 81420108022, 81272143, 51525203, 31300824, 81701948); Natural Science Foundation of Jiangsu Province (BK20150292, 20150293, 20150294); Suzhou Municipal Science and Technology Project (SYS201565, SYS201759); Key Laboratory of Suzhou (SZS201307); Suzhou Clinical Medicine Center (Szzxj201505); Jiangsu Natural Science Fund for Distinguished Young Scholars (BK20130005); Jiangsu Higher Education Institutions (Priority Academic Program Development) | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Accepted Version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.citation | Zhao, H., Zeng, Z., Liu, L., Chen, J., Zhou, H., Huang, L., Huang, J., Xu, H., Xu, Y., Chen, Z., Wu, Y., Guo, W., Wang, J. H., Wang, J. and Liu, Z. (2018) 'Polydopamine nanoparticles for treatment of acute inflammation-induced injury', Nanoscale. doi:10.1039/C8NR00838H | en |
dc.identifier.doi | 10.1039/C8NR00838H | |
dc.identifier.issn | 2040-3364 | |
dc.identifier.journaltitle | Nanoscale | en |
dc.identifier.uri | https://hdl.handle.net/10468/5695 | |
dc.language.iso | en | en |
dc.publisher | Royal Society of Chemistry | en |
dc.rights | © 2018, the Authors. Published by the Royal Society of Chemistry. All rights reserved. This document is the accepted version of an article published in final form in Nanoscale. To access the final published work see http://dx.doi.org/10.1039/C8NR00838H | en |
dc.subject | Polydopamine | en |
dc.subject | Acute inflammation injury | en |
dc.subject | Reactive oxygen species | en |
dc.subject | Anti-inflammation therapy | en |
dc.title | Polydopamine nanoparticles for treatment of acute inflammation-induced injury | en |
dc.type | Article (peer-reviewed) | en |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 2.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: